| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $98,4500 | +4,05% | $1,44B | $90,85K | |
TMP Tompkins Financial Corporation | $99,1790 | -1,07% | $1,44B | $19,77K | |
BRUN Boost Run Inc. Class A Common Stock | $18,7090 | -7,05% | $1,44B | $1,23M | |
TWFG TWFG, Inc. Common Stock | $27,2850 | +1,89% | $1,44B | $66,23K | |
PCT PureCycle Technologies, Inc. Common stock | $7,2350 | +5,16% | $1,44B | $1,17M | |
REX REX American Resources Corp. | $44,2100 | +0,20% | $1,43B | $20,74K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,8750 | -5,69% | $1,43B | $32,99K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6490 | +0,26% | $1,43B | $9,23K | |
ADNT Adient plc Ordinary Shares | $19,8300 | +1,80% | $1,43B | $102,14K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $37,4270 | -0,35% | $1,43B | $390,65K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8350 | -9,13% | $1,43B | $336,05K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $17,1490 | +0,82% | $1,42B | $18,69K | |
REPL Replimune Group, Inc. | $15,0190 | -3,60% | $1,42B | $1,51M | |
HCSG Healthcare Services Group | $23,2850 | +6,13% | $1,42B | $216,06K | |
